185 related articles for article (PubMed ID: 22225652)
21. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
22. Psychosocial outcomes and health service use after notifying women participating in population breast screening when they have dense breasts: a BreastScreen Queensland randomised controlled trial.
Nickel B; Ormiston-Smith N; Hammerton L; Cvejic E; Vardon P; Mcinally Z; Legerton P; Baker K; Isautier J; Larsen E; Giles M; Brennan ME; McCaffery KJ; Houssami N
Med J Aust; 2023 Nov; 219(9):423-428. PubMed ID: 37751916
[TBL] [Abstract][Full Text] [Related]
23. Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk-stratified population screening.
Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
Med J Aust; 2021 Oct; 215(8):359-365. PubMed ID: 34374095
[TBL] [Abstract][Full Text] [Related]
24. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
25. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia.
Roder D; Houssami N; Farshid G; Gill G; Luke C; Downey P; Beckmann K; Iosifidis P; Grieve L; Williamson L
Breast Cancer Res Treat; 2008 Apr; 108(3):409-16. PubMed ID: 18351455
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
[TBL] [Abstract][Full Text] [Related]
27. Impact of hormone replacement therapy use on mammographic screening outcomes.
Beckmann KR; Farshid G; Roder DM; Hiller JE; Lynch JW
Cancer Causes Control; 2013 Jul; 24(7):1417-26. PubMed ID: 23649232
[TBL] [Abstract][Full Text] [Related]
28. Impact of socio-economic status on breast cancer screening in women with diabetes: a population-based study.
Chan W; Yun L; Austin PC; Jaakkimainen RL; Booth GL; Hux J; Rochon PA; Lipscombe LL
Diabet Med; 2014 Jul; 31(7):806-12. PubMed ID: 24588332
[TBL] [Abstract][Full Text] [Related]
29. Selected breast cancer risk factors and early detection of the neoplasm in women from Lublin region attending screening program in St. John's Cancer Center, years 2005-2006.
Surdyka JA; Surdyka D; Stanisławek A; Starosławska E; Patyra KI
Ann Agric Environ Med; 2014; 21(4):792-8. PubMed ID: 25528922
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Modifiable Breast Cancer Risk Factors and Potential Opportunities for Primary Prevention Among Women Engaged in Screening Mammography: National Health Interview Survey Results.
Chowdhry DN; Miles RC; Escamilla Guevara A; Flores EJ; Narayan AK
J Breast Imaging; 2023 Sep; 5(5):538-545. PubMed ID: 38416916
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.
Wu H; Zhu K; Jatoi I; Shah M; Shriver CD; Potter J
Breast Cancer Res Treat; 2007 Mar; 101(3):317-24. PubMed ID: 16821080
[TBL] [Abstract][Full Text] [Related]
32. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
33. Proportion of women with self-reported opportunistic mammography before organized screening.
Heikkinen S; Miettinen J; Koskenvuo M; Huovinen R; Pitkäniemi J; Sarkeala T; Malila N
Acta Oncol; 2016 Jul; 55(7):865-9. PubMed ID: 27144814
[TBL] [Abstract][Full Text] [Related]
34. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme.
Séradour B; Estève J; Heid P; Jacquemier J
J Med Screen; 1999; 6(2):99-102. PubMed ID: 10444729
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for breast cancer in women with a breast cancer family history.
Egan KM; Stampfer MJ; Rosner BA; Trichopoulos D; Newcomb PA; Trentham-Dietz A; Longnecker MP; Mittendorf R; Greenberg ER; Willett WC
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):359-64. PubMed ID: 9610783
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
